Binding of herpes simplex virus-1 US11 to specific RNA sequences
Herpes simplex virus-1 US11 is a RNA-binding protein with a novel RNA-binding domain. US11 has been reported to exhibit sequence- and conformation-specific RNA-binding, but the sequences and conformations important for binding are not known. US11 has also been described as a double-stranded RNA (dsR...
Saved in:
Published in: | Nucleic acids research Vol. 33; no. 19; pp. 6090 - 6100 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Oxford University Press
01-01-2005
Oxford Publishing Limited (England) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Herpes simplex virus-1 US11 is a RNA-binding protein with a novel RNA-binding domain. US11 has been reported to exhibit sequence- and conformation-specific RNA-binding, but the sequences and conformations important for binding are not known. US11 has also been described as a double-stranded RNA (dsRNA)-binding protein. To investigate the US11–RNA interaction, we performed in vitro selection of RNA aptamers that bind US11 from a RNA library consisting of >1014 80 base sequences which differ in a 30 base randomized region. US11 bound specifically to selected aptamers with an affinity of 70 nM. Analysis of 23 selected sequences revealed a strong consensus sequence. The US11 RNA-binding domain and ≤46 bases of selected RNA containing the consensus sequence were each sufficient for binding. US11 binding protected the consensus motif from hydroxyl radical cleavage. RNase digestions of a selected aptamer revealed regions of both single-stranded RNA and dsRNA. We observed that US11 bound two different dsRNAs in a sequence non-specific manner, but with lower affinity than it bound selected aptamers. The results define a relatively short specific sequence that binds US11 with high affinity and indicate that dsRNA alone does not confer high-affinity binding. |
---|---|
Bibliography: | istex:6B7C0929408FA180830248DFE0ED316B17D8A598 local:gki919 ark:/67375/HXZ-LW98GD57-S To whom correspondence should be addressed. Tel: +1 617 432 1691; Fax: +1 617 432 3833; Email: Don_Coen@hms.harvard.edu ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 Hongming Wang, Pfizer Global Research and Development, Ann Arbor, MI, USA Present addresses: J. Colin Cox, Department of Biochemistry, Duke University Medical Center, Durham, NC, USA |
ISSN: | 0305-1048 1362-4962 |
DOI: | 10.1093/nar/gki919 |